← Taiwan Stock Snapshot Database

Home / Indicator library / Biotechnology and Medical Care / Polylite (1813) overview

Polylite (1813) stock overview

Valuation, financials, growth, ownership, events, dividends, models and adjusted prices for Polylite, on one page

中文版 (Chinese)

Polylite (1813) snapshot, key figures

Price / earnings
46.52x
Price / book
—
Dividend yield
0.00%
Revenue YoY (2026-09)
-6.9%
Monthly revenue (2026-09)
TWD 0.02bn
Sector
Biotechnology and Medical Care
Values above are the official-source snapshot for Polylite (1813) on 2026-11-02. We do not chase live quotes. Every trading day is frozen as its own point-in-time vintage, so a backtest reading this data sees only what was actually knowable that day, with no look-ahead bias. Missing values stay blank. Nothing is interpolated or extrapolated.

Polylite (1813): where today sits across the whole market

The same figures read against every other listed company on 2026-11-02, rather than against this ticker's own history.

Price / earnings46.52x84th percentile market-wide
10th pct8.79xmarket median17.42x90th pct64.70x
Dividend yield0.00%16th percentile market-wide
10th pct0.00%market median2.78%90th pct6.94%
Valid sample per metric: price / earnings 1,543, dividend yield 1,737. The three metrics are sampled independently rather than intersected, so the denominators differ — an intersection would turn every percentile into the percentile of whichever companies happen to disclose all three, a population nobody is asking about. Ratios at or below zero are excluded rather than counted as cheap; a zero dividend yield is kept because paying nothing is a real observation. The bar spans the 10th to 90th percentile, not the full range, because a handful of four-digit multiples would otherwise flatten every other company into the left edge; the percentile itself is computed on the full population and is unaffected.
The full decile structure behind these percentiles is on the market P/E, P/B and dividend yield distribution pages.
Checkup signals: 2 green / 3 amber / 2 red Full checkup →
Financial quality (F-score)Valuation percentile (P/E vs market)Revenue momentum (latest month, YoY)Ownership concentration (1,000-lot holders, weekly)Insider pledge ratioInsider disposal filings (last 60 days)Buyback announcements (last 12 months)

Seven-dimension checkup for this ticker →

Valuation river

→
P/E 46.52x · market rank 83rd percentile across the market

Financial quality

→
F-score quality checks passed: 4 of 6 checks that could be computed

Revenue growth

→
Monthly revenue, 2026-09: -6.9% year on year

Ownership structure

→
Large holders at 33.67%, +0.00 points week on week · insider pledge 0.0% as of 2026-08-31

Events, last 90 days

→
Loading…

Yield river

→
Cash dividend yield in the latest snapshot: 0.00%

Valuation models

→
Loading…

Adjusted-price candles

→
Loading…

1813: common questions

What is 1813's P/E ratio?

1813 traded at a price-to-earnings ratio of 46.52x in the official-source snapshot dated 2026-11-02. That figure is frozen as a point-in-time vintage, so a backtest reading it sees only what was knowable that day.

What is 1813's dividend yield?

1813's cash dividend yield was 0.00% on 2026-11-02. Historical dividend policy and gap-fill records are available on the same page.

How fast is 1813's revenue growing?

1813 reported -6.9% year-on-year monthly revenue growth for 2026-09, from the official monthly revenue filing.

How does 1813's price / earnings compare with the rest of the Taiwan market?

1813's price / earnings of 46.52x is above the market median of 17.42x and sits at the 84th percentile of the 1,543 tickers carrying a valid reading that day — 244 of them read higher. This is the cross-section on a single frozen date, a different question from where the ticker sits against its own past year.

How does 1813's dividend yield compare with the rest of the Taiwan market?

1813's dividend yield of 0.00% is below the market median of 2.78% and sits at the 16th percentile of the 1,737 tickers carrying a valid reading that day — 1,461 of them read higher. This is the cross-section on a single frozen date, a different question from where the ticker sits against its own past year.

Other Biotechnology and Medical Care tickers

159 Taiwan-listed tickers sit in this sector. See the full Biotechnology and Medical Care table.

Everything on this page is either the official public source shown as-is, or a transparent derivation you can reproduce. The free tier covers 2330 in full as a reference case; on other tickers some blocks are paid-tier. What we sell is data and tooling, not investment advice, not stock tips, and not a promise of returns.